麦斯莫医疗 MASI 深 沪
等待开盘 07-01 09:30:00 美东时间
179.95
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 179.95
- 总市值 94.24亿
- 52周最高 179.99
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 125.94
- 委 比 0.00%
- 总股本 5236.91万
- 历史最高 305.21
- 量 比 0
- 振 幅 0.00%
- 历史最低 17.62
- 每 手 1
- 风险率 16.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多QuidelOrtho plans to sell testing unit for $1.5B: FT
QuidelOrtho (QDEL) is looking to sell its point-of-care testing unit at a $1.5B valuation, and private equity groups have already expressed interest in the transaction, The Financial Times reported on...
06-27 20:28
Record-setting healthcare M&A activity to extend through H2: PwC
Healthcare dealmaking is already at the highest level since the pandemic, and the momentum is expected to continue into H2 2026, driven by looming patent cliffs and consumer demand for areas such as w...
06-26 01:59
Danaher Corp(DHR)股票6月24日盘中上涨4.91%：投资者必看的核心信息
• 丹纳赫（Danaher）本月完成了对Masimo公司价值99亿美元的收购。 • Masimo的一款AI辅助呼吸抑制检测系统获得了FDA的批准。 • 徕卡生物系统（Leica Biosystems）在PRW实验室推出了其首款高通量数字病理扫描仪。
06-24 17:16
QuidelOrtho taps former Masimo executive Micah Young as CFO
QuidelOrtho (QDEL) has named Micah Young as chief financial officer, effective July 6, 2026. Young will succeed Joseph Busky, who previously announced his retirement. Busky will remain with the compan...
06-23 19:22
QuidelOrtho names Micah Young CFO, succeeding Joseph Busky
QuidelOrtho names Micah Young CFO, succeeding Joseph Busky QuidelOrtho named Micah Young chief financial officer, effective July 6, 2026. Young was previously executive vice president and CFO at Masimo, joining in 2017 during a strategic transformation and transaction activity. He also held senior f
06-23 19:12
Masimo Receives FDA Clearance For Opioid-Induced Respiratory Depression Detection Capability Combined Into Its Radius VSM
Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, today announced FDA 510(k) clearance for an opioid-induced respiratory depression detection capability integrated into the Radius VSM® wearable continuous patient monit...
06-22 20:06
丹纳赫完成99亿美元收购Masimo 获机构中性评级
经济观察网 丹纳赫完成对迈心诺的99亿美元收购，获机构中性评级，当前股价处于技术面低位。 近期事件： 公司已于2026年6月10日正式完成对Masimo（迈心诺...
06-18 03:40
丹纳赫99亿美元出手！血氧巨头易主
6月10日，丹纳赫宣布，完成对Masimo（迈心诺）的收购。 99亿美元！从2月17日签约到交割，不到四个月。Masimo从纳斯达克退市，一家全球脉搏血氧龙头...
06-15 17:30
百亿美金！丹纳赫完成收购
6月10日，丹纳赫（Danaher）正式宣布，已完成此前宣布的对玛西莫（Masimo）的收购。 今年2月，双方曾宣布达成收购协议。根据协议，丹纳赫将以每股18...
06-12 17:40
Danaher completes acquisition of Masimo
Danaher completes acquisition of Masimo Danaher completed its acquisition of Masimo, making the patient-monitoring specialist a wholly owned subsidiary. Masimo shares stopped trading on Nasdaq. Masimo will keep its brand, operating as a stand-alone company within Danaher’s Diagnostics segment. Danah
06-10 20:56
